Mechanisms of Mycobacterium avium pathogenesis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 6, 2000, Pages 521-527

  Bermudez, Luiz E ^a   Wagner, Dirk ^a   Sosnowska, Danuta ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

Author keywords

M. avium; Pathogenesis

Indexed keywords

AIDS RELATED COMPLEX; ANIMAL; ATYPICAL MYCOBACTERIOSIS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; INTESTINE MUCOSA; MACROPHAGE; MICROBIOLOGY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; PATHOGENICITY; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; HUMANS; INTESTINAL MUCOSA; MACROPHAGES; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

EID: 0034572035     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. ABEL L., SANCHEZ F. O., OBERTI J., THUC N. V., HOA L. V., LAP V. D., SKAMENE E., LAGRANGE P. H. and SCHURR E. (1998): Susceptibility to leprosy is linked to the human NRAMP1 gene. J. Infect. Dis., 177, 133-145.
2. AGRANOFF D., MONAHAN I. M., MANGAN J. A., BUTCHER P. D. and KRISHNA S. (1999): Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J. Exp. Med., 190, 717-724.
3. AITKEN M. L., BURKE W., MCDONALD G., WALLIS C., RAMSEY B. and NOLAN C. (1993): Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest, 103, 1096-1099.
4. ALTARE F., DURANDY A., LAMMAS D., EMILE J. F., LAMHAMEDI S., LE DEIST F., DRYSDALE P., JOUANGUY E., DOFFINGER R., BERNAUDIN F., JEPPSSON O., GOLLOB J. A., MEINL E., SEGAL A. W., FISCHER A., KUMARARATNE D. and CASANOVA J. L. (1998): Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science, 280, 1432-1435.
5. APPELBERG R., CASTRO A. G., PEDROSA J., SILVA R. A., ORME I. M. and MINOPRIO P. (1994): Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and dependent phases of Mycobacterium avium infection. Infect. Immun., 62, 3962-3971.
6. BARKER L. P., GEORGE K. M., FALKOW S. and SMALL P. L. (1997): Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect. Immun., 65, 1497-1504.
7. BARTON C. H., BIGGS T. E., BAKER S. T., BOWEN H. and ATKINSON P. G. (1999): Nramp1: a link between intracellular iron transport and innate resistance to intracellular pathogens. J. Leukoc. Biol., 66, 757-762.
8. BELLAMY R., RUWENDE C., CORRAH T., MCADAM K. P., WHITTLE H. C. and HILL A. V. (1998): Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med., 338, 640-644.
9. BENTRUP K. H. Z., MICZAK A., SWENSON D. L. and RUSSELL D. G. (1999): Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J. Bacteriol., 181, 7161-7167.
10. BERMUDEZ L. E. (1993): Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin. Exp. Immunol., 91, 277.
11. BERMUDEZ L. E. (1993): Production of transforming growth factor β by Mycobacterium avium infected macrophages is associated with unresponsiveness to interferon-gamma. J. Immunol., 150, 1838-1843.
12. BERMUDEZ L. E. and CHAMPSI J. (1993): Infection with M. avium induces production of IL-10 and administration of IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun., 61, 3093-3096.
13. BERMUDEZ L. E. and GOODMAN J. (1996): Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun., 64, 1400-1406.
14. BERMUDEZ L. E., GOODMAN J. and PETROFSKY M. (1999): Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice. Infect. Immun., 67, 4912-4916.
15. BERMUDEZ L. E., KOLONOSKI P. and YOUNG L. S. (1990): Natural killer cell activity and macrophage dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model. J. Leukoc. Biol., 47, 135-142.
16. BERMUDEZ L. E., MARTINELLI J., PETROFSKY M., KOLONOSKI P. and YOUNG L. S. (1994): Recombinant granulocyte-macrophage colony stimulating factor enhances the effects of antibiotics against M. avium complex. J. Infect. Dis., 169, 575-580.
17. BERMUDEZ L. E., PARKER A. and GOODMAN J. R. (1997): Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor- independent pathway. Infect. Immun., 65, 1916-1925.
18. BERMUDEZ L. E. and PETROFSKY M. (1999): Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells. Infect. Immun., 67, 3108-3111.
19. BERMUDEZ L. E., PETROFSKY M. and GOODMAN J. (1997): Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells. Infect. Immun., 65, 3768-3773.
20. BERMUDEZ L. E., PETROFSKY M., KOLONOSKI P. and YOUNG L. S. (1992): An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract. J. Infect. Dis., 165, 75-79.
21. BERMUDEZ, L. E., PETROFSKY M., WU M. and YOUNG L. S. (1998): Clarithromycin significantly improves interleukin-12-mediated anti- Mycobacterium avium activity and abolishes toxicity in mice. J. Infect. Dis., 178, 896-899.
22. BERMUDEZ L. E., SANGARI F. J., PETROFSKY M. and GOODMAN J. (1998): Mycobacterium avium invasion. In Molecular signals and infectious diseases. Institut Pasteur Centre of Information Scientifique, 17-26.
23. BERMUDEZ L. E., SHELTON K. and YOUNG L. S. (1995): Comparison of the ability of M. avium, M. smegmatis, and M. tuberculosis to invade and replicate within HEp-2 epithelial cells. Tuber. Lung Dis., 76, 240-247.
24. BERMUDEZ L. H., STEVENS P., KOLONOSKI P., WU M. and YOUNG L. S. (1989): Treatment of disseminated Mycobacterium avium complex infection in mice with recombinant interleukin-2 and tumor necrosis factor. J. Immunol., 143, 2996-3002.
25. BERMUDEZ L. E. and YOUNG L. S. (1988): Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol., 9, 3006-3013.
26. BERMUDEZ L. E. and YOUNG L. S. (1989): Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex. Microb. Pathol., 7, 289-297.
27. BERMUDEZ L. E. and YOUNG L. S. (1990): Recombinant granulocyte-macrophage colony stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J. Leukoc. Biol., 48, 67-73.
28. BERMUDEZ L. E. and YOUNG L. S. (1991): Natural killer cell dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J. Immunol., 146, 265-269.
29. BERMUDEZ L. E. and YOUNG L. S. (1994):. Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex. Infect. Immun., 62, 2021-2026.
30. BERMUDEZ L. E., YOUNG L. S. and ENKEL H. (1991): Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins. Infect. Immun., 59, 1697-1702.
31. BLANCHARD D. K., MICHELINI-NORRIS M. B., PEARSON C. A., FREITAG C. S. and DJEU J. Y. (1991): Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes. Blood, 77, 2218-2224.
32. BODMER T., MILTNER E. and BERMUDEZ L. E. (2000): Mycobacterium avium resists exposure to the acidic conditions of the stomach. FEMS Microbiol. Lett., 182, 45-49.
33. CASTRO A. G., SILVA R. A. and APPELBERG R. (1995): Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. J. Immunol., 155, 2013-2019.
34. CLEMENS D. L. and HORWITZ M. A. (1995): Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med., 181, 257-270.
35. CURTIS K. J. and SLEISENGER M. H. (1978): Infections and parasitic diseases. In SLEISENGER M. H. and FORDHAM J. S. (eds.): Gastrointestinal diseases. Saunders, Philadelphia.
36. DAMSKER B. and BOTTONE E. J. (1985): Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis. J. Infect. Dis., 151, 179-181.
37. DE CHASTELLIER C. and LANG T. (1995): Phagocytic processing of the macrophages endoparasite Mycobacterium avium in comparison which contain Bacillus subtilus or latex beads. Eur. J. Cell Biol., 68, 167-182.
38. DENIS M. (1991): Tumor necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill M. avium: killing effect mechanism depends on the generation of reactive nitrogen intermediates. J. Leukoc. Biol., 49, 380-387.
39. DOHERTY T. M. and SHER A. (1997): Defects in cell-mediated immunity after chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol., 158, 4822-4831.
40. DORMAN S. E. and HOLLAND S. M. (1998): Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Invest., 101, 2364-2369.
41. ESCUYER V., HADDAD N., FREHEL C. and BERCHE P. (1996): Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium. Microb. Pathog., 20, 41-55.
42. FALKINHAM J. O. 3rd. (1996): Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev., 9, 177-215.
43. FREHEL C., DE CHASTELLIER C., LANG T. and RASTOGI N. (1986): Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun., 52, 252-262.
44. FUJIMURA Y. (1986): Functional morphology of microfold cells (M cells) in Peyer's patches-phagocytosis and transport of BCG by M cells into rabbit Peyer's patches. Gastroenterol. Jpn., 21, 325-335.
45. GLOVER N., HOLZMAN A., ARONSON T., PROMAN B., BERLIN G. W., DOMINGUEZ P., KONZEL K. A., OVERTURF G., STELMA G., SMITH C. and YAKNES M. (1994): The isolation and identification of Mycobacterium avium complex recovered from Los Angeles potable water, a possible source of infection in AIDS patients. Int. J. Environ. Health Res., 4, 63-72.
46. GOMES M. S., FLORIDO M., PAIS T. F. and APPELBERG R. (1999): Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol., 162, 6734-6739.
47. GOMES M. S., PAUL S., MOREIRA A. L., APPELBERG R., RABINOVITCH M. and KAPLAN G. (1999): Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect. Immun., 67, 3199-3206.
48. GRUENHEID S., CANONNE-HERGAUX F., GAUTHIER S., HACKAM D. J., GRINSTEIN S. and GROS P. (1999): The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J. Exp. Med., 189, 831-841.
49. HACKAM D. J., ROTSTEIN O. D., ZHANG W., GRUENHEID S., GROS P. and GRINSTEIN S. (1998): Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med., 188, 351-364.
50. HUBBARD R. D., FLORY C. M. and COLLINS F. M. (1992): T-cell immune responses in Mycobacterium avium-infected mice. Infect. Immun., 60, 150-153.
51. INDERLIED C. B., KEMPER C. A. and BERMUDEZ L. E. (1993): The Mycobacterium avium complex. Clin. Microbiol. Rev., 6, 266-310.
52. ISEMAN M. D. (1989): Mycobacterium avium complex and the normal host: the other side of the coin. N. Engl. J. Med., 321, 896-898.
53. JACOBSON M. A., HOPEWELL P. C., YAJKO D. M., HADLEY W. K., LAZARUS E., MOHANTY P. K., MODIN G. W., FEIGAL D. W., CUSICK P. S. and SANDE M. A. (1991): Natural history of disseminated Mycobacterium avium complex infection in AIDS. J. Infect. Dis., 164, 994-998.
54. JEPSON M. A. and CLARK M. A. (1998): Studying M cells and their role in infection. Trends Microbiol., 6, 359-365.
55. JUNG H. C., ECKMANN L., YANG S. K., PANJA A., FIERER J., MORZYCKA-WROBLEWSKA E. and KAGNOFF M. F. (1995): A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest., 95, 55-65.
56. KEMPER C. A., BERMUDEZ L. E. and DERESINSKI S. C. (1998): Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. J. Infect. Dis., 177, 914-920.
57. KIM S. Y., GOODMAN J. R., PETROFSKY M. and BERMUDEZ L. E. (1998): Mycobacterium avium infection of gut mucosa in mice associated with late inflammatory response and intestinal cell necrosis. J. Med. Microbiol., 47, 725-731.
58. KOBAYASHI K., KASAMA T., YAMAZAKI J., HOSAKA M., KATSURA T., MOCHIZUKI T., SOEJIMA K. and NAKAMURA R. M. (1995): Protection of mice from Mycobacterium avium infection by recombinant interleukin 12. Antimicrob. Agents Chemother., 39, 1369-1371.
59. MANPOTHER M. E. and SANGER J. G. (1984): In vitro interaction of Mycobacterium avium with intestinal epithelial cells. Infect. Immun., 45, 67-73.
60. MOMOTANI E., WHIPPLE D. L., THIERMANN A. B. and CHEVILLE N. F. (1988): The role of M cells and macrophages in the entrance of Mycobacterium paratuberculosis into domes of ileal Peyer's patches in calves. Vet. Pathol., 25, 131-137.
61. NEWMAN G. W., KELLEY T. G., GAN H. and REMOLD H. (1993): Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increase M. avium multiplication and altered cytokine production. J. Immunol., 151, 2261-2272.
62. OGATA K., LINZER B. A., ZUBERIA R. I., GANZ T., WEBER R. and CATANZARO A. (1992): Activity of defensins from human neutrophilic granulocytes against M. avium-M. intracellulare. Infect. Immun., 60, 4720-4725.
63. SANGARI F. and BERMUDEZ L. E. (1999): Cloning of the kdp transport system of Mycobacterim avium. ASM General Meeting.
64. SANGARI F., GOODMAN J. R. and BERMUDEZ L. E. (2000): Ultrastructural study of Mycobacterium avium infection of HT-29 human intestinal epithelial cells. J. Med. Microbiol., 49, 139-147.
65. SANGARI F. J., PETROFSKY M. and BERMUDEZ L. E. (1999): Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES. Infect. Immun., 67, 5069-5075.
66. SARMENTO A. and APPELBERG R. (1996): Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. Infect. Immun., 64, 3224-3230.
67. SAUNDERS B. M. and CHEERS C. (1995): Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect. Immun., 63, 2282-2287.
68. SAUNDERS B. M., ZHAN Y. and CHEERS C. (1995): Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect. Immun., 63, 4011-4015.
69. SCHLESINGER L. S. (1993): Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol., 150, 2920-2930.
70. SCHLESINGER L. S., BELLINGER-KAWAHARA C. G., PAYNE N. R. and HORWITZ M. A. (1990): Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol., 144, 2771-2780.
71. SCHOREY J. S., CARROLL M. C. and BROWN E. J. (1997): A macrophage invasion mechanism of pathogenic mycobacteria. Science, 277, 1091-1093.
72. SCHOREY J. S., HOLSTI M. A., RATLIFF T. L., ALLEN P. M. and BROWN E. J. (1996): Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria. Mol. Microbiol., 21, 321-329.
73. SHIRATSUCHI H., JOHNSON J. L., TOOSSI Z. and ELLNER J. J. (1994): Modulation of the effector function of human monocytes for Mycobacterium avium by HIV-1 envelope glycoprotein 120. J. Clin. Invest., 93, 885-891.
74. STURGILL-KOSZYCKI S., SCHLESINGER P. H., CHAKRABORTY P., HADDIX P. L., COLLINS H. L., FOK A. K., ALLEN R. D., GLUCK S. L., HEUSER J. and RUSSELL D. G. (1994): Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase (published erratum appears in Science 1994 Mar 11;263(5152):1359). Science, 263, 678-681.
75. TOKURAKU K., NAKAGAWA H., KISHI F. and KOTANI S. (1998): Human natural resistance-associated macrophage protein is a new type of microtubule-associated protein. FEBS Lett., 428, 63-67.
76. WAGNER D., PARKER A., WU M. and BERMUDEZ L. E. (1999): Cloning a putative iron transport gene in Mycobacterium avium. ASM General Meeting.
77. WEINSTEIN D. L., O'NEILL B. L. and METCALF E. S. (1997): Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6. Infect. Immun., 65, 395-404.
78. WOLINSKY E. (1979): Nontuberculous mycobacteria and associated diseases. Am. Rev. Respir. Dis., 119, 107-159.
79. WRIGHT S. D. and SILVERSTEIN S. (1983): Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med., 158, 2016-2026.